Mechanistic insights into promotion of non-small cell lung cancer by BAG5 using integrative multi-omics approaches.
These findings underscore the potential oncogenic role of BAG5 in NSCLC, revealing that it acts through multiple molecular pathways. Our study suggests that targeting BAG5 could be a promising therapeutic strategy for treating NSCLC.
Authors
- Jiamei Wang (ORCID: https://orcid.org/0000-0003-3724-0561)
- Baiqiang Li
- Zhengyu Yu (ORCID: https://orcid.org/0000-0002-8057-2847)
- Fu-Ying Zhao
- Hao Liang (ORCID: https://orcid.org/0000-0001-7534-5124)
- Jing-Shan Huang (ORCID: https://orcid.org/0009-0006-1977-303X)
- Ye Yuan (ORCID: https://orcid.org/0000-0002-9512-8888)
- Hua‐Qin Wang
Institutions
- Liaoning Cancer Hospital & Institute (CN)
- China Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1648139
- Primary Topic
- Molecular Biology Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Doctoral Start-up Foundation of Liaoning Province